Pediatric Pharmacology Flashcards
Define the following:
1. Preterm or premature
- Neonate
- Infant
- Child
- Adolescent
- less than 36 weeks gestational age
- First 30 days of life
- 1 month to 1 year of age
- 1-12 years old
- 12-18 years old
Variables affecting GI absorption
5
- pH
- Gastric emptying time and GI motility
- Pancreatic enzyme activity
- GI surface area
- Intestinal microorganisms
Variables affecting GI absorption: How does pH differ in children?
3
- More alkaline than adults until child reaches 1 year
- Adversely affects the absorption of weakly acid drugs
- improves the absorption of weakly basic drugs
Variables affecting GI absorption: How does Gastric emptying time and GI motility different in children?
- Slower than adults for the first month of life
2. Neonates and infants have irregular peristalsis
Variables affecting GI absorption:
- Pancreatic enzyme activity?
- Example? - GI surface area? 2
- Pancreatic enzyme activity
- Decreased for the first year of life compared to adults
- Affects drugs that are fat soluble (not absorbed)
- Example: Neonates cannot absorb Vitamin E - GI surface area
- Intestinal size relative to body size matters
- In young children the relative size of the duodenum compared with the adults enhances drug absorption
Variables affecting GI absorption: GI microorganisms in children?
3
Example?
- Intestinal flora depends MORE on diet than age
- More rapid development of flora in breast fed infants
- Flora is active in the breakdown of various drugs
Example: Digoxin is reduced to inactive metabolites by anaerobic intestinal bacteria. Digoxin metabolites are not detected in children until about 16 months of age and adult like reduction of digoxin does not occur until age 9.
Rectal absorption 1. Who should we use this in? 2. Drug is absorbed by what? (avoids what) 3. What is the issue with this route?
Example?
- For patients who cannot tolerate oral drugs or lack IV access
- Drug is absorbed by the hemorrhoidal veins and avoids first pass hepatic metabolism
- Most drugs administered by this route are erratically and incompletely absorbed
Example: Diazepam, valproic acid or secobarbital may be given PR in status epilepticus when lacking IV access
IM absorption
- Affected by? 4
- Neonates? 3
- Infants?
- Affected by
- Muscle mass,
- blood flow to the muscle
- tone
- activity - Neonates
- Decreased muscle mass
- limited muscle activity decreases blood flow to and from the muscle
- Erratic and poor drug absorption - Infants
- Greater density of skeletal muscle capillaries than older children therefore more efficient absorption
- Percutaneous absorption: Affected by? 2
2. Neonates have thin skin and increased BSA relative to body mass = how is this significant?
- Affected by
- Thickness of the skin
- Body surface area relative to body mass - significant percutaneous drug absorption in neonates compared to adults
Factors affecting distribution in pediatric patients
7
- Vascular perfusion
- Body composition
- Tissue binding characteristics
- Physiochemical properties of the drug
- Plasma protein binding
- Route of administration
- Neonates – these factors are significantly different from adults
- Vascular perfusion?
Ex?
- Changes in perfusion are common in neonates
Ex: in response to hypoxia the blood may be diverted (shunted) from the lungs to the tissues and organs
The higher the total body water and extracellular water the ________ the volume of distribution?
larger
- Neonates and infants have _________ total body water and ECF compared to older children and adults
- Some drugs will require a ________ dose per Kg in infants and younger compared to adults
- increased
2. larger
Tissue binding characteristics: Drugs bound to tissues exhibit increased free blood levels when what?
when the mass of tissue is reduced such as in pediatrics
- Physiochemical properties that are different in children? 2
These properties affect the ability of the drug to move across membranes into target tissues and cells
- Lipid solubility
- Molecular configuration
Regarding percutaneous absorption, may lead to toxicity in the neonate